While CgA levels are generally associated with tumor burden and differentiation status, up to 30–50% of patients with neuroendocrine neoplasms may exhibit normal CgA values, which can impact diagnostic and monitoring accuracy [5,6,7]. The gene discussed is CGA; the disease is neoplasm.